| References: |
GSK690693 is a pan-AKT kinase inhibitor, is also an aminofurazan-derived inhibitor of Akt kinases with potential antineoplastic activity. Pan-AKT kinase inhibitor GSK-690693 binds to and inhibits Akt kinases 1, 2, and 3, which may result in the inhibition of protein phosphorylation events downstream from Akt kinases in the PI3K/Akt signaling pathway, and, subsequently, the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. In addition, this agent may inhibit other protein kinases including protein kinase C (PKC) and protein kinase A (PKA). As serine/threonine protein kinases which are involved in a number of biological processes, AKT kinases promote cell survival by inhibiting apoptosis and are required For glucose transport. Check For active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).
For the detailed information about the solubility of GSK690693 in water, the solubility of GSK690693 in DMSO, the solubility of GSK690693 in PBS buffer, the animal experiment（test） of GSK690693,the in vivo,in vitro and clinical trial test of GSK690693,the cell experiment（test） of GSK690693,the IC50, EC50 and Affinity of GSK690693, please contact DC Chemicals. |
